High-throughput screening and optimization experiments are critical to a number of fields, including chemistry and structural and molecular biology. The separation of these two steps may introduce false negatives and a time delay between initial screening and subsequent optimization. Although a hybrid method combining both steps may address these problems, miniaturization is required to minimize sample consumption. This article reports a ''hybrid'' droplet-based microfluidic approach that combines the steps of screening and optimization into one simple experiment and uses nanoliter-sized plugs to minimize sample consumption. Many distinct reagents were sequentially introduced as Ϸ140-nl plugs into a microfluidic device and combined with a substrate and a diluting buffer. Tests were conducted in Ϸ10-nl plugs containing different concentrations of a reagent. Methods were developed to form plugs of controlled concentrations, index concentrations, and incubate thousands of plugs inexpensively and without evaporation. To validate the hybrid method and demonstrate its applicability to challenging problems, crystallization of model membrane proteins and handling of solutions of detergents and viscous precipitants were demonstrated. By using 10 l of protein solution, Ϸ1,300 crystallization trials were set up within 20 min by one researcher. This method was compatible with growth, manipulation, and extraction of high-quality crystals of membrane proteins, demonstrated by obtaining high-resolution diffraction images and solving a crystal structure. This robust method requires inexpensive equipment and supplies, should be especially suitable for use in individual laboratories, and could find applications in a number of areas that require chemical, biochemical, and biological screening and optimization.
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droplets ͉ plugs ͉ protein structure ͉ high-throughput ͉ miniaturization T his work reports a ''hybrid'' microfluidic approach that uses nanoliter plugs to perform screening and optimization simultaneously in the same experiment. To validate this method using a challenging problem, we demonstrate its compatibility with crystallization of membrane proteins. Small-scale screening and optimization experiments are important for biological assays, chemical screening, and protein crystallization (1) (2) (3) . Screening and optimization are usually carried out sequentially. In the case of protein crystallization, random sparse matrix screening initially identifies the precipitants that may lead to crystallization. Subsequent gradient optimization establishes concentrations of these precipitants that lead to diffractionquality crystals (4) . Combining screening and optimization steps into a single hybrid experiment would eliminate the need to wait for the outcome of the initial screen before carrying out subsequent optimizations. Furthermore, a hybrid experiment would reduce the false negatives (5) associated with screens performed at a single concentration. The hybrid experiment could also be more conclusive, because a single batch of the sample would be used for both screening and optimization. Simultaneous screening and optimization could increase consumption of samples, so miniaturization is essential for the success of the hybrid method. Such a hybrid method could be especially valuable for the crystallization of membrane proteins.
Determining crystal structures of membrane proteins is the focus of major research efforts, with significant recent progress (6) (7) (8) (9) (10) . Membrane proteins control a number of cellular signaling pathways and are targets of Ͼ50% of pharmaceutical drugs (11, 12) . Crystallization of membrane proteins remains challenging (13, 14) , because samples are often limited in quantity (15) and may be unstable over time. Also, an extensive range of crystallization conditions must be searched, including screening detergents used to solubilize membrane proteins (15) (16) (17) . Technologies for miniaturization of crystallization experiments are needed, but handling solutions of membrane proteins is complicated by their low surface tension and high viscosity. To address these challenges, both robotic (18, 19) and microfluidic (20) (21) (22) (23) technologies have been developed to screen crystallization conditions on a submicroliter scale for both soluble and membrane proteins, but no universally applicable technology has yet emerged. Given the complexity of the problem of crystallization of membrane proteins, it is unlikely that a single technology would provide a universal solution, but there is a clear need for miniaturized technologies sufficiently robust, simple, and inexpensive to be accessible to individual laboratories.
Results
Developing a Plug-Based Hybrid Screening Method. To perform simultaneous hybrid screening and optimization, we used plugs [droplets surrounded by fluorinated carrier fluid and transported through microfluidic channels (24) ]. Plugs have been used to perform the initial screening in a number of applications, including biochemical assays (25), chemical reactions (26) , and crystallization of soluble proteins (22) . In separate experiments, plugs have been used for optimization of protein crystallization conditions (23) . Implementation of the hybrid method while minimizing sample consumption and labor was enabled by four key developments ( Fig. 1): (i) To deliver many distinct reagents in the same experiment, as required for the initial screen, we used a preformed array of reagent plugs, each plug Ϸ120-140 nl in volume. Each pair of plugs in the array was separated by Ϸ40-nl spacer to ensure reliable transport of reagent plugs of different viscosities and surface tensions (22, 27) . As this array was flowed from the cartridge into the microfluidic device, each plug formed a long segment that could be manipulated as a continuous stream (Fig. 1a) . This stream was combined with the streams of buffer (24) and substrate at a microfluidic junction. The three streams flowed continuously and laminarly into a flowing stream of fluorinated carrier fluid, forming a series of Ϸ50 small plugs (10-15 nl) as each 140-nl plug of reagent combined with buffer and substrate. An array of 20 reagents produced Ϸ1,000 small plugs. (ii) For each reagent, to accomplish an optimization simultaneously with the initial screen, each of Ϸ50 small plugs contained a different concentration of the reagent. We used a LabView subroutine for computer-controlled pumps to vary the relative flow rates of the three streams, producing plugs containing different ratios (and different concentrations) of the reagent, buffer, and substrate (Fig. 1b) . When the flow rates were changed in steps, each step produced a group of plugs with similar concentration. Higher flow rate of a stream corresponded to a proportionally higher concentration of that stream in the plug (Fig. 1c) . Even with simple syringe pumps, concentrations may be controlled reliably over a 16-fold range (28) . (iii) To ensure that the optimization covers a full range of concentrations of each reagent, two approaches are possible. In the first, the arrival of each reagent plug is synchronized with the start of a computer subroutine that gradually changes the f low rate. Although such synchronization is possible when the volumes of reagents and spacers are known precisely, it complicates the procedure significantly and is not robust. We used the second approach, in which the subroutine gradually changes the f low rate of the reagent up and down and then repeats the cycle [see supporting information (SI) Fig. 5 ]. No synchronization was required in this approach as long as each reagent produced small plugs over a period longer than one up/down cycle, regardless of where the cycle started; each reagent produced at least one small plug of each concentration (Fig. 1d) . A cycle with a gradual increase and an abrupt decrease is less redundant and saves substrate, but we found that abrupt changes of f low rate were more difficult to control precisely, possibly because of elasticity of poly(dimethlysiloxane) (PDMS). In addition, Ϸ2-fold redundancy (Fig. 1d ) of this method provided an internal check of reproducibility. (iv) To index the concentration of reagents in hundreds of plugs generated by this method, we relied on sensitivity of the size of the plug to the ''water fraction'' (29), the ratio of the combined volumetric flow rates of the aqueous streams to the total flow rate of the carrier fluid and the aqueous streams. At higher water fractions, larger plugs form (29) . As the computer subroutine increased the relative flow rate of the reagent stream, it also decreased the flow rate of the buffer to keep the combined volumetric flow rates of the three aqueous streams constant. At the same time, the subroutine increased the flow rate of the carrier fluid, decreasing the water fraction and decreasing the size of the plugs. Within a series of Ϸ40 plugs containing the same reagent, the concentration of a reagent in each plug was inferred by measuring the size of the plug relative to the size of plugs in the beginning and the middle of the up/down cycle ( Fig. 1 c and d) . The size of plugs changes approximately linearly with water fraction, and we found the dependence to be slightly sensitive to viscosity (SI Fig. 6 ). Calibration would be required for very accurate measurements of concentrations directly from sizes of plugs. To identify which series of plugs contained which reagent, we relied on plugs of the spacer fluid separating these series of plugs.
Implementing the Hybrid Method to Handle Solutions of Membrane
Proteins. We chose crystallization of membrane proteins to validate this hybrid approach. We chose this problem both because of its relevance and the challenges in fluid handling it presents. This validation was enabled by two technical developments: the use of perfluoroamines as carrier fluids and the use of Teflon capillaries for the formation, transport, and storage of plugs (Fig. 2) . Formation of plugs occurs at low values of the dimensionless capillary number, Ca ϭ U/␥, where U (m⅐s Ϫ1 ) is the f low velocity, (kg⅐m Ϫ1 ⅐s Ϫ1 ) is the dynamic viscosity, and ␥ (kg⅐s Ϫ2 ) is the surface tension at the interface between the aqueous phase and the carrier f luid (30) . Perf luoroalkane-based carrier f luids, previously used for crystallization of soluble proteins (23), did not support formation of plugs of solutions containing membrane proteins and detergents. The high viscosity and low surface tension of these solutions increased the value of Ca above the usable range of Ca Ͻ Ϸ0.1. We were able to control the surface chemistry at the aqueous-f luorous interface (31) by identifying two perf luoroamines, FC-40 (a mixture of perf luoro-tri-n-butylamine and perf luoro-di-n-butylmethylamine) and FC-70 (perf luorotripentylamine), that provided a sufficiently high surface tension of 10 -12 mN/m with the typical detergent solutions [e.g., 0.1% (wt/vol) lauryldimethylamine oxide (LDAO)].
To transport plugs through microchannels, the carrier fluid must wet the walls of the microchannels preferentially. Native PDMS surfaces did not support formation of plugs, because solutions of detergents wet them. Microchannels with either PDMS surfaces modified with a fluorinated silane (31) or native Teflon surfaces can be used to form plugs, because they are preferentially wet by FC-40 and FC-70. To form plugs, we used a thin-walled Teflon capillary, cut at an angle and inserted from the outlet of the PDMS device up to the plug-forming junction (Fig. 2a) . Plugs formed without contacting the PDMS walls of the channel and flowed directly into the Teflon capillary (Fig.  2b) . Plugs flowed reliably through long (Ͼ1 m) Teflon capillaries, because flow of plugs through channels of circular crosssection minimizes drainage of the carrier fluids and undesired coalescence of plugs (32, 33) .
For short-term incubation, we used a 1-m-long capillary to store Ͼ1,000 crystallization trials in a compact format and at a cost of Ͻ1 cent per trial (Fig. 2c) . Both the carrier fluid and water evaporated through 25-m thin walls of amorphous Teflon, with a loss of 48% of water over 12 days. This evaporation could be used to increase the concentration of the components inside plugs to drive crystallization (20, 23) in analogy to a vapordiffusion trial. For long-term incubation, Teflon capillaries were placed inside glass tubes (Fig. 2d) filled with the carrier fluid, reducing evaporation of the aqueous phase to below detection limit (0.5%) over 60 days. Switching between incubation with and without glass tubing allows one to stop and start evaporation at will or to perform crystallizations under microbatch (34) conditions.
We quantified the formation of plugs in the hybrid method by using reaction center (RC) from Rhodopseudomonas viridis (7.0 mg/ml) in a solution of LDAO [0.05% (wt/vol) in 10 mM Tris, pH 7.8]. Three aqueous reagents with viscosities ranging from Ϸ1 mPa s (water) to Ϸ6 mPa s [50% glycerol (wt/wt)] to Ϸ36 mPa s [25% (wt/vol) PEG 8000] were used to mimic the viscosities of common precipitants. To visualize the hybrid method, we added absorption dyes to these solutions (Fig. 1c) . To measure concentrations quantitatively (standard dilution curves shown in SI Fig. 7) , we used fluorescent dyes (Fig. 1d) but used a solution of LDAO instead of RC, because fluorescence of RC obscured the fluorescence of dyes. For all solutions, regardless of viscosity, increasing concentrations of precipitants corresponded to decreasing sizes of plugs, as expected ( Fig. 1 c  and d) .
Before setting up crystallization trials in a particular detergent, the detergent was added to the precipitants in the screen and to the buffer. We found that detergents could be lost from solutions upon contact with hydrophobic PDMS. We have not yet established whether these losses occur by adsorption to the surface, or by absorption into PDMS. We found that losses were significant when submicroliter volumes of solutions of detergents with a low critical micelle concentration (CMC), such as ndodecyl-␤-D-Maltopyranoside [CMC Ϸ0.17 mM (0.0087%) in water], were flowed through Ϸ1 cm of a PDMS microfluidic channel. To reduce these losses, we used short inlet channels in PDMS devices. In addition, when using detergents with a low CMC, we primed the inlet channels with a solution of this detergent. Solutions of detergents with higher CMC, such as LDAO [CMC Ϸ1 mM (0.023%) in water] did not require priming. Once the solutions formed plugs in Teflon capillary, the layer of fluorinated carrier fluid surrounding the plugs prevented the loss of detergent to hydrophobic surfaces.
We performed hybrid crystallization screens under microbatch conditions (without evaporation) by using a custom-made screening kit of 48 precipitants with concentrations approximately twice those used in traditional vapor-diffusion screens. We measured the solubility of typical precipitants in FC-40 and FC-70 using NMR (SI Table 1 ) and established that detergents and some alcohols (such as ethanol and 2R,3R-butanediol) had solubilities of Ͻ10 Ϫ2 M [Ϸ0.02% (vol/vol)]. Ethanol was the most soluble at 8.5 ϫ 10 Ϫ3 M in FC-40. We concluded that the loss of these detergents and precipitants into the carrier fluids should not significantly affect the crystallization experiments.
Testing Compatibility of the Hybrid Method with Crystallization of
Model Membrane Proteins. We used two model proteins to test the compatibility of the hybrid method with membrane protein crystallization. By obtaining high-resolution diffraction of crystals of these proteins, we wished to confirm that all technical hurdles were identified and overcome successfully. To test handling of precipitants with high viscosity, we used 3.5 l of Porin from Rhodobacter capsulatus [29.8 mg/ml in 0.6% (wt/vol) n-octyltetraoxyethylene (C 8 E 4 ) and 20 mM Tris pH 7.8]. We used a viscous precipitant with viscosity of Ϸ250 mPa s [containing 70% (wt/vol) PEG 550MME and 3 M LiCl] chosen to approximate reported (35) crystallization conditions. We used two plugs of this precipitant in a hybrid screen together with seven other precipitants (SI Table 2 ). Using 3.5 l of the protein, starting with a premade array of precipitant plugs, we set up Ϸ450 crystallization trials in 6 min. Only the smallest plugs [30% (wt/vol) PEG 550MME, 1.9% (wt/vol) C 8 E 4 , and 1.3 M LiCl] produced Porin crystals, whereas plugs of lower concentration (larger size) were all clear. Crystals (Fig. 3b) formed in both series of plugs containing PEG 550MME, confirming that fluid handling was performed correctly and that the system was compatible with crystallization of this protein.
To test whether the conditions could be scaled up to obtain larger crystals, we repeated the screen in a larger device fitted with a silanized glass capillary 600 m in diameter. Larger plugs gave larger crystals (Fig. 3c) . In situ x-ray data collection (36) (37) (38) directly in capillaries was carried out at 4°C by using synchrotron radiation. Single shots showed that the Porin crystals diffracted up to 1.95 Å (Fig. 4a) with mosaicity Ͻ0.3°, establishing that crystals of high-quality could be formed and that these crystals could be manipulated in plugs without any damage. We conducted a hybrid screen of RC (22 mg/ml/0.08% LDAO/7% heptane-triol/4.5% triethylammonium phosphate solution in 20 mM Na 2 HPO 4 /NaH 2 PO 4 buffer, pH 6.0) using a total of 20 reagent plugs of 18 precipitants (SI Table 3 ). In addition to 16 precipitants from the custom-made kit, we used 2 precipitants, both in duplicate plugs: one was a positive control based on the original crystallization condition (39, 40) [4M (NH 4 ) 2 SO 4 in 50 mM Na 2 HPO 4 /NaH 2 PO 4 buffer pH 6.0], and another was a modified crystallization condition at higher pH [3.6 M (NH 4 ) 2 SO 4 in 50 mM Tris, pH 7.8]. The duplicates were placed at random positions within the array of precipitants. By using 10 l of protein for these 18 precipitants, 1,300 crystallization trials were set up within 20 min. Both the positive control and the modified condition induced crystallization. As the concentration of the ammonium sulfate increased from plug to plug (detected by the decrease in the sizes of plugs), we observed the expected trend: a mixture of the protein solution with light precipitation, progressing to single crystals, and then progressing to microcrystals (Fig. 3a) . Reagents that did not lead to crystals also showed characteristic transitions. For example, PEG 6000-based precipitant caused precipitation at low concentrations, whereas it caused phase separation at higher concentrations (Fig. 3a) . The transition was reproducible within pairs of duplicates, confirming the correlation between size and concentration as well as a lack of cross-contamination.
We assessed the quality of the crystals of RC obtained in a hybrid screen and tested the compatibility of this method with cryocrystallography. Crystals were slowly (to reduce shear) flowed out of the Teflon capillary and into a solution of paraffin oil as the cryoprotectant. We did not observe any crystals adhering to the walls of the Teflon capillary, presumably because of the layer of the fluorinated carrier fluid separating the plugs from the wall (24, 36) . Crystals were then looped and flashfrozen in liquid nitrogen. X-ray data were collected at 100 K by using synchrotron radiation. The RC crystal grown at the original conditions (pH 6.0) diffracted up to 2.5 Å. Before data collection, this crystal was stored in Teflon capillary surrounded by FC-70 in a glass capillary for Ϸ2 months, confirming that long-term storage of crystals in plugs does not damage them. The modified condition (pH 7.8) gave better crystals, diffracting to 1.9 Å (Fig. 4b) . Two of these crystals were used to collect a complete (96.5%) x-ray data set. Because of radiation damage, the resolution cutoff was 1.96 Å. The average mosaicity was Ͻ0.3°. The RC structure was refined to R factor of 17.2% (R free 18.6%) with well defined electron density for protein and solvent parts of the structure (Fig. 4c) . This experiment confirmed that high-quality crystals can be grown directly in Ϸ10-nl plugs of the hybrid screen and extracted from the capillary without damage for traditional data collection at cryogenic temperatures.
Discussion
The microfluidic hybrid method described in this article provides a simple and economical procedure for simultaneous screening and optimization in nanoliter volumes. The use of plugs simplifies this approach: multiple distinct reagents are introduced serially without cross-contamination, reagents and substrate are combined by using a single passive microfabricated feature (a junction of channels), producing hundreds of plugs, with each plug representing an independent experiment. These plugs are flowed into an inexpensive piece of capillary and stored and monitored there without evaporation or damage to crystals. Overall, we found this method to be effective and now routinely use it in our laboratory. Within 1 h, using simple syringe pumps and only 17 l of a substrate solution, a single researcher has set up a hybrid screen for 48 different reagents (Ϸ40 plugs per reagent) to sample a total of Ϸ1,900 experimental conditions. We expect this method to operate on smaller scales as well, because the capillary number that governs fluid flow in these systems is not explicitly sensitive to the dimensions of the channels or plugs. Such miniaturization would require arrays of reagents in smaller plugs (41) and reliable pumping at lower flow rates.
A volume of Ϸ10 nl proved to be the optimal volume for plugs used for crystallization of model membrane proteins: it saved sample but contained enough protein to produce crystals of sufficient size and quality for high-resolution diffraction. Extracting and manipulating crystals grown in plugs was also straightforward, making this system compatible with both cryo (4) and in situ (36) (37) (38) x-ray diffraction. This method overcame the challenges associated with handling of solutions of membrane proteins and provided control of wetting, evaporation, and loss of detergents. Here, we have shown that this hybrid method is compatible with crystallization of membrane proteins. To establish its ultimate usefulness, one would need to screen a panel of 20-30 new, but biochemically well characterized, membrane proteins. Our laboratory does not yet have access to such a panel of proteins, but there is a significant effort to produce them under the Protein Structure Initiative and under the National Institutes of Health Roadmap (www.nigms.nih.gov/ Initiatives/PSI/Centers/ and http://nihroadmap.nih.gov/structuralbiology/index.asp). We welcome both disseminating this technology and receiving such panels of samples for testing in our laboratory.
Having successfully handled solutions of membrane proteins, it was not surprising that this method had no problems handling aqueous solutions free of detergents. We have used this method to implement crystallization screens with commercial kits from Hampton Research (Aliso Viejo, CA) and Emerald Biostructures (Bainbridge Island, WA). We do not anticipate problems performing enzymatic assays with this method (22, 28) , but it remains to be established whether this method is compatible with screening of samples containing live cells, an area that could also benefit from a nanoliter hybrid screen. We used optical detection in all of the experiments, by using a microscope scanning stage or by pulling the capillary with plugs through the microscope's field of view. This method would benefit from simple automated systems for detection in plugs, either optical or based on mass spectrometry (26) . Beyond crystallization, we believe this method would find applications in a number of areas (5, (42) (43) (44) (45) (46) of chemistry, biochemistry, molecular biology, and material science that require simultaneous screening and optimization economically and in small volumes.
Materials and Methods
See SI Supporting Text for detailed procedures and additional characterizations and control experiments.
Microfluidic Hybrid Experiments. Preformed arrays (41) and microfluidic devices (28, 31) were prepared as described previously, by using mask design and dimensions as in SI Fig. 8 Tables 2 and 3. X-Ray Diffraction and Structure Determination. X-ray data collection details are given in SI Table 4 and Fig. 10 . A detailed flow chart outlining the procedures for the hybrid experiments is shown in SI Fig. 11 .
Crystallization details are in the SI

